Upon revisiting PAP and its glycosylationspecifically, it appears to be a promising new biomarker candidate.Namely, previous studies have indicated that PAP glycoforms differbetween PCa and non-PCa individuals. This evidence concerns the gene ACP3 and posterior cortical atrophy.